The T2DM group also showed significantly lower eGFR, beta cell function (HOMA-beta, HOMA2-beta), glucose effectiveness (Sg), and insulin sensitivity in the glucose clamp (GDR, M/1) than the non-DM group. The gene discussed is INS; the disease is type 2 diabetes mellitus.